Mounjaro 2.5mg
Mounjaro 2.5mg is the recommended starting dose for all patients beginning tirzepatide therapy. As a dual GIP/GLP-1 receptor agonist, Mounjaro works on two incretin pathways simultaneously. This introductory dose lets your body adjust to this dual mechanism while keeping side effects manageable.
Dose at a Glance
- Generic Name
- tirzepatide
- Dose
- 2.5mg
- Frequency
- Once weekly
- Half-Life
- ~5 days
- Typical Duration
- 4 weeks
- Dose Type
- Starting dose
What to Expect on Mounjaro 2.5mg
- •Mild appetite suppression as GIP and GLP-1 receptors are activated
- •Possible mild nausea or stomach upset in the first few days
- •Some patients notice reduced cravings even at this starting dose
- •Minimal weight loss expected at this introductory level
- •Your body building tolerance to the dual-agonist mechanism
Common Side Effects
- •Mild nausea (usually resolves within a few days)
- •Decreased appetite
- •Diarrhea (more common with tirzepatide than semaglutide)
- •Mild abdominal discomfort
- •Occasional injection site reactions
Where This Dose Fits in Titration
The 2.5mg dose is the starting point for all Mounjaro patients. After 4 weeks, your provider will typically increase to 5mg. The Mounjaro titration has more available dose levels (2.5mg through 15mg) than semaglutide products, allowing for finer dose adjustments.
Tips for Mounjaro 2.5mg
Note that Mounjaro has a shorter half-life (~5 days) than semaglutide, so you may notice effects wearing off before your next dose
Keep meals light and balanced during the first week to minimize nausea
Start tracking in JellyPal immediately to capture your baseline experience
Stay hydrated, as GI side effects can affect fluid balance
Explore Other Mounjaro Doses
Track Your Mounjaro 2.5mg Doses
Log every injection, visualize your medication levels with our PK plotter, track side effects, and see a countdown to your next dose. JellyPal supports all Mounjaro (tirzepatide) dose levels.
View Mounjaro TrackerThis page is for informational purposes only and is not medical advice. It does not recommend or adjust any dose. Mounjaro (tirzepatide) is a prescription medication that should only be used under the supervision of a qualified healthcare provider. Never start, stop, or change your dose without first talking to your doctor.
Frequently Asked Questions
Track your dose with confidence.
Stay on top of your Mounjaro journey with injection logging, level tracking, and side-effect insights you can share with your doctor.
